LDL susceptibility to oxidation and HDL antioxidant capacity in patients with renal failure

被引:36
作者
Jurek, A
Turyna, B
Kubit, P
Klein, A
机构
[1] Jagiellonian Univ, Fac Biotechnol, Dept Gen Biochem, PL-30387 Krakow, Poland
[2] Rydygier Hosp, Dept Nephrol & Dial, Krakow, Poland
关键词
low density lipoprotein; high density lipoprotein; lipid peroxidation; renal failure; atherosclerosis;
D O I
10.1016/j.clinbiochem.2005.08.009
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: This study examines the susceptibility to oxidation and the ability to stimulate reactive oxygen species of LDL from hemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD) patients. It was also designed to evaluate the antioxidant activity of HDL from uremic patients. Design and methods: Lipoprotein properties were determined in 28 HD patients, 30 CAPD patients and 30 control subjects by spectrophotometric, chemiluminescence and electrophoresis methods. Results: CAPD LDL were more resistant to oxidation than control LDL. HD and control LDL, in contrast to CAPD LDL, stimulated reactive oxygen species generation in granulocytes. The HDL ability to protect LDL against oxidation was impaired in renal patients. Conclusions: The risk of atherosclerosis development in patients with renal failure does not appear to be related to less resistance of LDL to oxidation, but rather to the decreased HDL antioxidant capacity. (c) 2005 The Canadian Society of Clinical Chemists. All rights reserved.
引用
收藏
页码:19 / 27
页数:9
相关论文
共 50 条
[1]   Apolipoprotein B-containing lipoproteins in renal failure: The relation to mode of dialysis [J].
Attman, POA ;
Samuelsson, OG ;
Moberly, J ;
Johansson, AC ;
Ljungman, S ;
Weiss, LG ;
Knight-Gibson, C ;
Alaupovic, P .
KIDNEY INTERNATIONAL, 1999, 55 (04) :1536-1542
[2]   Premature cardiovascular disease in chronic renal failure [J].
Baigent, C ;
Burbury, K ;
Wheeler, D .
LANCET, 2000, 356 (9224) :147-152
[3]   HIGH-DENSITY-LIPOPROTEIN IS A SCAVENGER OF SUPEROXIDE ANIONS [J].
CHANDER, R ;
KAPOOR, NK .
BIOCHEMICAL PHARMACOLOGY, 1990, 40 (07) :1663-1665
[4]   The oxidative modification hypothesis of atherogenesis: An overview [J].
Chisolm, GM ;
Steinberg, D .
FREE RADICAL BIOLOGY AND MEDICINE, 2000, 28 (12) :1815-1826
[5]  
Dantoine TF, 1998, J AM SOC NEPHROL, V9, P2082
[6]  
Dirican M, 2004, J NEPHROL, V17, P813
[7]  
EISENBERG S, 1984, J LIPID RES, V25, P1017
[8]   EFFECT OF ANTIOXIDANTS ON OXIDATIVE MODIFICATION OF LDL [J].
ESTERBAUER, H ;
PUHL, H ;
DIEBERROTHENEDER, M ;
WAEG, G ;
RABL, H .
ANNALS OF MEDICINE, 1991, 23 (05) :573-581
[9]   CONTINUOUS MONITORING OF INVITRO OXIDATION OF HUMAN LOW-DENSITY LIPOPROTEIN [J].
ESTERBAUER, H ;
STRIEGL, G ;
PUHL, H ;
ROTHENEDER, M .
FREE RADICAL RESEARCH COMMUNICATIONS, 1989, 6 (01) :67-75
[10]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499